doi: 10.1093/ejendo/lvad098 37 AbdallaMAShahNDeshmukhHSahebkarAstlundhLAl-RifaiRHet al
Vitiligo studies involve selected patients and often combine afamelanotide with phototherapy
This might include specific directions on when to take each medication, how often to take it, and what to avoid while on the medication
This growth is fueled by landmark cardiovascular outcomes trials (e.g., LEADER, REWIND, EMPA-REG OUTCOME) demonstrating that GLP-1 agonists reduce major adverse cardiovascular events (MACE) in patients with type 2 diabetes and established cardiovascular disease or high risk
If stacking with AAS or SARMs , follow your full PCT protocol using [PCT Stacks](PCT Stacks) , Clomid , or Nolvadex as needed
If you have diabetes or take medication to regulate blood sugar, alcohol consumption while on GLP-1 therapy requires explicit discussion with your prescribing clinician